{{Short description|Precursor of a hormone}}
...in segments inaccessible. Prohormones can travel the [[blood stream]] as a hormone in an inactivated form, ready to be activated later in the cell by [[post-t
...
7 KB (1,035 words) - 20:02, 23 April 2024
...lactation/ja|授乳]]、[[Motor coordination/ja|運動]]、[[reproduction/ja|生殖]]、および[[hormone/ja|ホルモン]]によって引き起こされる[[sensory perception/ja|感覚知覚]]。専門は行動内分泌学と[[comparative
...1つのホルモン（[[Thyroid-stimulating hormone/ja|甲状腺刺激ホルモン]]など）が別の二次ホルモン（[[thyroid hormone/ja|甲状腺ホルモン]]など）の作用や放出を制御する。二次ホルモンが多すぎると、一次ホルモンに負のフィードバックを与え、[[homeostasis/j
...
22 KB (746 words) - 20:58, 20 February 2024
{{Short description|Precursor of a hormone}}
...in segments inaccessible. Prohormones can travel the [[blood stream]] as a hormone in an inactivated form, ready to be activated later in the cell by [[post-t
...
7 KB (1,069 words) - 20:02, 23 April 2024
...docrine system'''）は、[[gland/ja|腺]]から直接[[circulatory system/ja|循環系]]に放出される[[hormone/ja|ホルモン]]のフィードバックループからなる[[organism/ja|生物]]のメッセンジャーシステムであり、遠くの臓器を標的として調節する。[
...蔵する細胞内液胞または顆粒を持つ。対照的に、[[salivary gland/ja|唾液腺]]、[[sweat gland/ja|汗腺]]、および[[Human gastrointestinal tract/ja|消化管]]内の腺などの外分泌腺は、脈管がはるかに少なく、管または中空の[[Lumen (anato
...
34 KB (989 words) - 16:52, 13 April 2024
...ation|movement]], [[reproduction]], and [[sensory perception]] caused by [[hormone]]s. Specializations include behavioral endocrinology and [[comparative endo
...organs, and, conversely, one target organ may be affected by more than one hormone.
...
17 KB (2,368 words) - 13:43, 20 February 2024
...ation|movement]], [[reproduction]], and [[sensory perception]] caused by [[hormone]]s. Specializations include behavioral endocrinology and [[comparative endo
...organs, and, conversely, one target organ may be affected by more than one hormone.
...
18 KB (2,440 words) - 13:43, 20 February 2024
{{Short description|Hormone-producing glands of a body}}
| Caption = Main [[Endocrine gland|glands]] of the human endocrine system
...
30 KB (4,228 words) - 20:42, 17 January 2024
...e, but still available to the human body for performing the same action as human insulin in terms of [[Diabetes management#Glycemic control|controlling bloo
...insulin). The first insulin analog (insulin Lispro rDNA) was approved for human therapy in 1996 and was manufactured by [[Eli Lilly and Company]].
...
16 KB (2,314 words) - 17:50, 19 March 2024
{{Short description|Hormone-producing glands of a body}}
| Caption = Main [[Endocrine gland|glands]] of the human endocrine system
...
30 KB (4,330 words) - 20:41, 17 January 2024
...e, but still available to the human body for performing the same action as human insulin in terms of [[Diabetes management#Glycemic control|controlling bloo
...insulin). The first insulin analog (insulin Lispro rDNA) was approved for human therapy in 1996 and was manufactured by [[Eli Lilly and Company]].
...
16 KB (2,362 words) - 17:49, 19 March 2024
...、[[resistin/ja|レジスチン]]、[[cytokine/ja|サイトカイン]]（特に[[TNF-alpha/ja|TNFα]]）などの[[hormone/ja|ホルモン]]を産生するため、主要な[[endocrine/ja|内分泌]]臓器として認識されている。肥満では、脂肪組織は[[adipokines
人間には脂肪組織がある：[[human skin/ja|皮膚]]の下（[[subcutaneous fat/ja|皮下脂肪]]）、内部の[[Organ (anatomy)/ja|臓器]]の周
...
38 KB (1,012 words) - 08:25, 28 February 2024
...urces—human, animal, plant, fungal, or microbial. They can be used in both human and animal medicine.<ref>{{Cite journal|last=Walsh|first=Gary|date=2018|tit
...ced therapy medicinal products: Overview |url=https://www.ema.europa.eu/en/human-regulatory/overview/advanced-therapy-medicinal-products-overview |access-da
...
29 KB (3,642 words) - 16:31, 3 January 2023
{{Human body weight}}
...edication]]s alter one of the fundamental processes of the [[human anatomy|human body]], [[body weight|weight]] regulation, by: [[anorectic|reducing appetit
...
17 KB (2,406 words) - 18:16, 7 March 2024
{{Human body weight}}
...edication]]s alter one of the fundamental processes of the [[human anatomy|human body]], [[body weight|weight]] regulation, by: [[anorectic|reducing appetit
...
18 KB (2,460 words) - 18:15, 7 March 2024
[[cortisol/ja|コルチゾール]]、[[growth hormone/ja|成長ホルモン]]、[[human placental lactogen/ja|ヒト胎盤性ラクトゲン]]など、多くのホルモンがインスリン抵抗性を誘発する。
...
30 KB (665 words) - 09:52, 11 March 2024
...or|GLP-1 receptor]]. They mimic the actions of the endogenous [[incretin]] hormone [[GLP-1]] that is released by the gut after eating.
...P-1 agonists in rodents are mediated via increased synthesis of fibroblast growth factor 21 ([[FGF21]]). Dual GLP-1/FGF21 receptor agonists have been develop
...
13 KB (1,847 words) - 16:47, 13 April 2024
...or|GLP-1 receptor]]. They mimic the actions of the endogenous [[incretin]] hormone [[GLP-1]] that is released by the gut after eating.
...P-1 agonists in rodents are mediated via increased synthesis of fibroblast growth factor 21 ([[FGF21]]). Dual GLP-1/FGF21 receptor agonists have been develop
...
14 KB (1,899 words) - 16:46, 13 April 2024
...at included structural and functional characterization, animal study data, human pharmacokinetic and pharmacodynamics data, clinical immunogenicity data and
Cloning of human genetic material and development of in vitro biological production systems
...
21 KB (2,692 words) - 09:55, 20 March 2024
...clude severe illness, [[sepsis]], [[kidney failure]], [[liver disease]], [[hormone]] deficiency, [[tumor]]s such as [[insulinoma]]s or non-B cell tumors, [[in
...nt of glucose in the body, especially after meals. [[Glucagon]] is another hormone involved in regulating blood glucose levels, and can be thought of as the o
...
40 KB (5,542 words) - 21:49, 14 March 2024
...clude severe illness, [[sepsis]], [[kidney failure]], [[liver disease]], [[hormone]] deficiency, [[tumor]]s such as [[insulinoma]]s or non-B cell tumors, [[in
...nt of glucose in the body, especially after meals. [[Glucagon]] is another hormone involved in regulating blood glucose levels, and can be thought of as the o
...
37 KB (5,139 words) - 21:45, 14 March 2024